Halozyme Therapeutics Inc (HALO)

Industry Biotechnology

This stock can be held in an Investment ISA and an Investment Account

Sell

$66.69

Buy

$67.41

arrow-up$2.24 (+3.44%)

Prices updated at 20 Dec 2025, 00:53 EST

Prices minimum 15 mins delay

Prices in USD

Halozyme Therapeutics Inc is a biotechnology company. It is engaged in research on human enzymes that alter the extracellular matrix and tumor environment.

NASDAQ

1.31%

NASDAQ

Important documents: Please ensure that you have read the Pre-sale Illustrations document & Doing Business with Fidelity document (incorporating the Fidelity Client Terms) and

Our Investment Fees and Charges.

	$67.53 - $65.11
	$79.50 - $46.26
	-
	7,658.03m
	14.21
	-
	3,257,335
	15.72
	2,053,929.14
	0.73
	123.14m
	US40637H1095
	4.74
	-

Please note that past performance is not a reliable indicator of future returns. Pre-sale Illustration.

Important Information

Investment values, and income from investments, can go down as well as up, so you may get back less than you invest. This is not a personal recommendation for a specific investment. If you're not sure which investments are suitable for you, consult Fidelity's advisers or another authorised financial adviser. The information contained herein: is proprietary to Morningstar and/or its content providers; may not be copied or distributed; and is not warranted to be accurate, complete or timely. Neither Morningstar nor its content providers are responsible for any damages or losses arising from any use of this information.